Afterwards, the effect of HOTAIRM1 knockdown on MPP+-induced cellular oxidative stress damage is investigated, and the crosstalk of HOTAIRM1 and the Nrf2/HO-1 pathway is further researched, therefore providing certain ideas for finding therapeutic targets for PD. Here, HMOX1 is linked to Parkinson disease.